1AB

1AB is a strategic communications firm headquartered in Tampa, United States, that specializes in external communications for life sciences companies. Founded in 2017 by CEO Dan Budwick, the firm has built a practice focused on helping biotechnology, pharmaceutical, and medical device companies navigate complex communications challenges across all stages of development. With a team of 11 to 50 employees, 1AB provides a comprehensive suite of services designed to support clients from early-stage launches through to public market milestones and crisis management.

Services and Specialties

1AB offers a broad range of communications services tailored to the unique needs of life sciences organizations. The firm’s capabilities span earned, owned, and shared media, with a strong emphasis on media relations and executive counseling. Below is a representative list of services 1AB typically provides:

• Media relations and earned media strategy
• Corporate communications and external communications
• Investor relations and capital markets advisory
• Digital and social media strategy
• Executive counseling and presentation training
• Crisis communications and issues management
• Clinical trial communication support
• Drug approval and medical meeting support
• Journal publication support
• IPO and reverse merger communications

Who They Help

1AB primarily serves clients in the life sciences sector, including startups, publicly traded biopharma companies, and medical device firms. The firm works with organizations across various development phases, from preclinical and early-stage companies to those preparing for regulatory approvals or commercial launches. Their client base often includes management consulting firms, digital health companies, and entities involved in capital markets transactions such as IPOs or reverse mergers. 1AB’s expertise in biotechnology, pharmaceuticals, and medtech allows them to address the specific communications needs of these highly regulated industries, whether it’s explaining complex clinical data to investors or managing public perception during a product launch.

Approach and Philosophy

1AB emphasizes a tailored, hands-on approach to communications. Rather than applying a one-size-fits-all strategy, the firm works closely with C-suite executives to develop customized plans that align with each client’s stage of development and business objectives. Their methodology integrates earned media through strong journalist relationships, owned media through content creation and thought leadership, and shared media via digital and social channels. 1AB also provides consulting on capital markets advisory, helping life sciences companies communicate effectively with investors and analysts during key milestones such as funding rounds, drug approvals, or clinical trial readouts. The firm’s focus on executive counseling and presentation training ensures that leadership teams are prepared to deliver consistent, compelling messages across all stakeholders.

Location and Credentials

Based in Tampa, Florida, United States, 1AB operates from its headquarters at 12005 Whitmarsh Lane. While the firm is rooted in Tampa, its work spans national and international clients in the life sciences space. The team’s experience includes supporting companies through FDA approvals, clinical trial communications, and public market transitions. 1AB’s reputation in the public relations and communications field is built on its ability to navigate the intersection of science, business, and media, making it a practical choice for life sciences organizations seeking a specialized communications partner.

1AB is a good fit for life sciences companies—from biotech startups to publicly traded pharma firms—that need targeted, strategic communications support. Their services are particularly relevant for organizations facing regulatory milestones, capital markets events, or complex external communications challenges. With a focus on media relations, investor relations, and digital strategy, 1AB provides a focused alternative to larger, generalist agencies for clients in the biotechnology, pharmaceutical, and medtech sectors.